Welcome to this week's Sunday Briefing. In this edition:
Alberta wants to be a data centre hub
Nine cleantech projects get a share of $46M
Google accelerator cohort includes 14 Canadian AI companies
P.S. Did someone forward you this email? You can subscribe right here. And for real-time updates, follow us on Twitter and LinkedIn.
Calgary startup lands national distribution deal for catalytic wound care
Photo: NanoTess
Calgary-founded NanoTess has signed a distribution agreement with Embecta — the world's leading producer of insulin injection devices — to bring its flagship wound care product to more than 14,000 pharmacies across Canada.
The deal marks the first wound care product Embecta has distributed in Canada, and a significant step forward for NanoTess, which was co-founded in 2020 by Megan Leslie and Julian Mulia with the goal of improving how patients and healthcare systems treat chronic wounds and skin conditions.
At the centre of the partnership is NanoSALV Catalytic, a Health Canada-authorised medical device that optimises and accelerates the body's natural healing processes — particularly relevant for the four million-plus Canadians living with diabetes, who face 20 times the risk of non-traumatic lower limb amputations compared to the general population. Eighty-five percent of those amputations are preceded by foot ulcers.
For Leslie, the Embecta partnership is about closing the gap between innovation and access.
"Reducing barriers to care has always been our highest priority as a company. Our partnership with Embecta does exactly that, by making catalytic wound care accessible to every Canadian living with diabetes and every Canadian living with wound and skin concerns."
Jennifer Spearen, VP and General Manager of Embecta Canada, says demand for accessible, easy-to-use early intervention options has been building within the diabetes community for some time — and that NanoSALV Catalytic's Canadian origins are an added draw in the current market.
"It was developed and produced right here in Canada," she noted.
NanoSALV Catalytic is already listed on the Alberta Drug Benefit List and has been adopted by Alberta Health Services and BC Provincial Health Services Authority.
SPONSORED BY WEWORK
See how the workplace is changing
Whether you're an established enterprise or a scaling startup, find a coworking space that's right for you. Flexible workspaces can unlock value for both employees and your bottom line—regardless of your company size. Wework is designed to enhance the employee experience and help people do their best work. Connect with a WeWork expert today.
Want to reach Calgary tech leaders? Advertise in the Calgary Tech Journal to get in front of founders, investors, and innovators. Contact [email protected] to learn more.
📰 Need To Know
Alberta’s technology minister continues data centre courtship at Digital Innovation Forum. Nate Glubish pitches province's energy, low taxes, and cool climate. Betakit
Alberta invests $46M toward cleantech innovation in province’s energy sector. Delivered through Emissions Reduction Alberta, this funding will support nine real-world projects, including technologies to remove bitumen and chemicals from mine water, dry and settle tailings faster, and use wetlands to naturally and safely clean water. Calgary.Tech
Google for Startups Accelerator reveals 14 “AI-driven” companies in its Canadian cohort. The startups touch a variety of industries, including real estate, construction, agriculture, finance, manufacturing, e-commerce, healthcare, and life sciences. Betakit
SPONSORED BY HUBSPOT
The Future of AI in Marketing. Your Shortcut to Smarter, Faster Marketing.
This guide distills 10 AI strategies from industry leaders that are transforming marketing.
Learn how HubSpot's engineering team achieved 15-20% productivity gains with AI
Learn how AI-driven emails achieved 94% higher conversion rates
Discover 7 ways to enhance your marketing strategy with AI.